>>> Up
* Aviva Raised to Buy at HSBC; PT 555 pence
* Burberry Raised to Neutral at Mediobanca SpA; PT 850 pence
* DSV Raised to Outperform at BNPP Exane; PT 1,700 kroner
* DSV Raised to Outperform at BNPP Exane; PT 1,700 kroner
* Ericsson Nikola Tesla Raised to Buy at Erste Group; PT 227 euros
* InterContinental Hotels Raised to Overweight at Barclays
* Microsoft Raised to Buy at First Shanghai; PT $500
* Orsted Raised to Hold at DNB Markets; PT 390 kroner
* Shell Raised to Outperform at Grupo Santander; PT 3,000 pence
* Spirax Raised to Buy at HSBC; PT 8,000 pence
>>> Down
>>> Down
* Carlsberg Cut to Underweight at Barclays; PT 698 kroner
* CVC Capital Cut to Neutral at Citi; PT 22.60 euros
* Givaudan Cut to Underweight at Barclays; PT 3,750 Swiss francs
* Hugo Boss Cut to Add at Baader Helvea; PT 45 euros
* MARR SpA Cut to Neutral at Mediobanca SpA; PT 12.50 euros
* Netflix Cut to Hold at First Shanghai; PT $823je sais pas
* Nice Ltd ADRs Cut to Neutral at Piper Sandler; PT $187
* Nice Ltd ADRs Cut to Neutral at Piper Sandler; PT $187
* Nice Ltd ADRs Cut to Market Perform at Oppenheimer
* SMA Solar Cut to Sell at DZ Bank; PT 10 euros
* Treatt Cut to Underweight at Barclays; PT 480 pence
* Whitbread Cut to Equal-Weight at Barclays; PT 3,160 pence
>>> Initiation
>>> Initiation
* AbbVie Reinstated Outperform at Wolfe; PT $205
* Accelleron Rated New Outperform at Oddo BHF; PT 59 Swiss francs
* Amgen Reinstated Peerperform at Wolfe
* Bechtle Rated New Neutral at Redburn; PT 28.50 euros
* Biogen Reinstated Peerperform at Wolfe
* BioMarin Rated New Outperform at Wolfe; PT $95
* Bristol Myers Rated New Peerperform at Wolfe
* CDW Rated New Buy at Redburn; PT $230
* Eli Lilly Rated New Outperform at Wolfe; PT $1,000
* Gilead Rated New Outperform at Wolfe; PT $110
* Johnson & Johnson Rated New Outperform at Wolfe; PT $190
* Merck & Co Rated New Peerperform at Wolfe
* Pan African Rated New Overweight at ABSA Securities
* Per Aarsleff Rated New Buy at Nordea; PT 500 kroner
* Pfizer Rated New Underperform at Wolfe; PT $25
* Suedzucker Rated New Neutral at Matelan Research; PT 14.50 euros
>>> Call
* Suedzucker Rated New Neutral at Matelan Research; PT 14.50 euros
>>> Call